I am a Senior Computational Scientist at Space Peptides Pharmaceutical and a Scientific Collaborator at the University of Bern and the University of Basel. My work is defined by the intersection of molecular biology, peptide chemistry, and advanced computational engineering.
Currently, my primary focus is on AI-driven drug discovery and development. I specialize in:
Generative AI: Implementing generative models for de novo drug design and peptide optimization.
ML/AI Development: Building, training, and deploying machine learning models to accelerate therapeutic development.
Architecture & Pipelines: Designing and developing node-and-edge-based computational pipelines and custom web applications to bridge the gap between complex data and actionable insights.
With a PhD in Molecular Biology and a first-class BEng in Electrical and Electronic Engineering, I offer a unique hybrid perspective. I have spent over a decade in high-level research at institutions such as the University of Zurich and University College London (RVC), where I worked across cancer biology, genomics, and bioinformatics.
Beyond my primary research, I serve on the Editorial Board of Biochemical Genetics (Springer Nature). I am passionate about leveraging my background in control systems and biotechnology to create scalable, intelligent solutions for the future of medicine.
I am a Senior Computational Scientist at Space Peptides Pharmaceutical and a Scientific Collaborator at the University of Bern and the University of Basel. My work is defined by the intersection of molecular biology, peptide chemistry, and advanced computational engineering.
Currently, my primary focus is on AI-driven drug discovery and development. I specialize in:
Generative AI: Implementing generative models for de novo drug design and peptide optimization.
ML/AI Development: Building, training, and deploying machine learning models to accelerate therapeutic development.
Architecture & Pipelines: Designing and developing node-and-edge-based computational pipelines and custom web applications to bridge the gap between complex data and actionable insights.
With a PhD in Molecular Biology and a first-class BEng in Electrical and Electronic Engineering, I offer a unique hybrid perspective. I have spent over a decade in high-level research at institutions such as the University of Zurich and University College London (RVC), where I worked across cancer biology, genomics, and bioinformatics.
Beyond my primary research, I serve on the Editorial Board of Biochemical Genetics (Springer Nature). I am passionate about leveraging my background in control systems and biotechnology to create scalable, intelligent solutions for the future of medicine.